Usefulness of B-Type Natriuretic Peptide and Cardiac Troponin Levels to Predict In-Hospital Mortality from ADHERE

American Journal of Cardiology

Volumn 101, Issue 2, 2008, Pages 231-237

  Fonarow, Gregg C ^a   Peacock, William F ^c   Horwich, Tamara B ^a   Phillips, Christopher O ^c   Givertz, Michael M ^d   Lopatin, Margarita ^e   Wynne, Janet ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCIOS INC   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; NITROGEN; SODIUM; TROPONIN; TROPONIN I; TROPONIN T; UREA;

ADULT; AGE; AGED; ARTICLE; CREATININE BLOOD LEVEL; DYSPNEA; FEMALE; GENDER; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PULSE RATE; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

AGED; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; REGISTRIES; SURVIVAL ANALYSIS; TROPONIN I; UNITED STATES;

EID: 37549061014     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.07.066     Document Type: Article

References (25)

1. Morrow D.A., Cannon C.P., Jesse R.J., Newby L.K., Ravkilde J., Storrow A.B., Wu A.H., and Christenson R.H. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115 suppl (2007) e356-e375
2. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 110 suppl (2004) e82-e292
3. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 112 (2005) 1825-1852
4. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
5. Cowie M.R., Jourdain P., Maisel A., Dahlstrom U., Follath F., Isnard R., Luchner A., McDonagh T., Mair J., Nieminen M., and Francis G. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24 (2003) 1710-1718
6. Sato Y., Yamada T., Taniguchi R., Nagai K., Makiyama T., Okada H., Kataoka K., Ito H., Matsumori A., Sasayama S., and Takatsu Y. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103 (2001) 369-374
7. LaVecchia L.L., Mezzena G., Zanolla L., Paccanaro M., Varotto L., Bonanno C., and Ometto R. Cardiac troponin I as a diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 19 (2000) 644-652
8. Missov M., Calzolari C., and Pau B. Circulating cardiac Troponin I in severe congestive heart failure. Circulation 96 (1997) 2953-2958
9. Perna E.R., Macin S.M., Cimbaro Canella J.P., Alvarenga P.M., Rios N.G., Pantich R., Augier N., Farias E.F., Jantus E., Brizuela M., and Medina F. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Cardiol 99 (2005) 253-261
10. Del Carlo C.H., and O'Connor C.M. Cardiac troponins in congestive heart failure. Am Heart J 138 (1999) 646-653
11. Ishii J., Nomura M., Nakamura Y., Naruse H., Mori Y., Ishikawa T., Ando T., Kurokawa H., Kondo T., Nagamura Y., Ezaki K., and Hishida H. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89 (2002) 691-695
12. Horwich T.B., Patel J., MacLellan W.R., and Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality in advanced heart failure. Circulation 108 (2003) 833-838
13. You J.J., Austin P.C., Alter D.A., Ko D.T., and Tu J.V. Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J 153 (2007) 462-470
14. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., Braunwald E., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
15. Sabatine M.S., Morrow D.A., de Lemos J.A., Gibson C.M., Murphy S.A., Rifai N., McCabe C., Antman E.M., Cannon C.P., and Braunwald E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
16. Adams K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., Berkowitz R.L., Galvao M., and Horton D.P. Characteristics and outcomes of patients hospitalized for heart failure in the United States (2001-2003): rationale, design and preliminary observations from the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 49 (2005) 209-216
17. Fonarow G.C., Adams Jr. K.F., Abraham W.T., Yancy C.W., and Boscardin W.J. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
18. Yancy C.W., Lopatin M., Stevenson L.W., de Marco T., and Fonarow G.C. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47 (2006) 76-84
19. Heidenreich P.A., and Fonarow G.C. Are registry hospitals different?. A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohorts. Am Heart J 152 (2006) 935-939
20. Abraham W.T., Adams K.F., Fonarow G.C., Costanzo M.R., Berkowitz R.L., LeJemtel T.H., Cheng M.L., and Wynne J. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46 (2005) 57-64
21. Harrison A., Morrison L.K., Krishnaswamy P., Kazanegra R., Clopton P., Dao Q., Hlavin P., and Maisel A.S. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39 (2002) 131-138
22. Maisel A., Hollander J.E., Guss D., McCullough P., Nowak R., Green G., Saltzberg M., Ellison S.R., Bhalla M.A., Bhalla V., Clopton P., and Jesse R. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44 (2004) 1328-1333
23. Januzzi Jr. J.L., Van Kimmenade R.R., Lainchbury R Bayes-Genis A., Ordonez-Llanos J., Santalo-Bel M., Pinto Y.M., and Richards M. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
24. Januzzi Jr. J.L., Sakhuja R., O'Donoghue M., Baggish A.L., Anwaruddin S., Chae C.U., Cameron R., Krauser D.G., Tung R., Camargo C.A., and Lloyd-Jones D.M. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med 166 (2006) 315-320
25. Fonarow C.G., and Horwich T.B. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. Rev Cardiovasc Med 4 suppl 4 (2003) S20-S28